IRIS Accounts Production v25.1.0.734 10466318 director 1.1.24 31.12.24 31.12.24 false true false false false true false A Ordinary 1.00000 B Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104663182023-12-31104663182024-12-31104663182024-01-012024-12-31104663182022-12-31104663182023-01-012023-12-31104663182023-12-3110466318ns15:EnglandWales2024-01-012024-12-3110466318ns14:PoundSterling2024-01-012024-12-3110466318ns10:Director12024-01-012024-12-3110466318ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3110466318ns10:SmallEntities2024-01-012024-12-3110466318ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3110466318ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110466318ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110466318ns10:FullAccounts2024-01-012024-12-311046631812024-01-012024-12-3110466318ns10:OrdinaryShareClass12024-01-012024-12-3110466318ns10:OrdinaryShareClass22024-01-012024-12-31104663181ns10:OrdinaryShareClass12024-01-012024-12-3110466318ns10:CompanySecretary12024-01-012024-12-3110466318ns10:RegisteredOffice2024-01-012024-12-3110466318ns5:CurrentFinancialInstruments2024-12-3110466318ns5:CurrentFinancialInstruments2023-12-3110466318ns5:ShareCapital2024-12-3110466318ns5:ShareCapital2023-12-3110466318ns5:SharePremium2024-12-3110466318ns5:SharePremium2023-12-3110466318ns5:RetainedEarningsAccumulatedLosses2024-12-3110466318ns5:RetainedEarningsAccumulatedLosses2023-12-3110466318ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110466318ns5:IntangibleAssetsOtherThanGoodwill2023-12-3110466318ns5:IntangibleAssetsOtherThanGoodwill2024-12-3110466318ns5:IntangibleAssetsOtherThanGoodwill2023-12-3110466318ns5:PlantMachinery2023-12-3110466318ns5:ComputerEquipment2023-12-3110466318ns5:PlantMachinery2024-01-012024-12-3110466318ns5:ComputerEquipment2024-01-012024-12-3110466318ns5:PlantMachinery2024-12-3110466318ns5:ComputerEquipment2024-12-3110466318ns5:PlantMachinery2023-12-3110466318ns5:ComputerEquipment2023-12-3110466318ns5:CostValuation2023-12-3110466318ns5:AdditionsToInvestments2024-12-3110466318ns5:DisposalsRepaymentsInvestments2024-12-3110466318ns5:CostValuation2024-12-3110466318ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110466318ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3110466318ns10:OrdinaryShareClass12024-12-3110466318ns10:OrdinaryShareClass22024-12-31
REGISTERED NUMBER: 10466318 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

STEM CELLX LIMITED

STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


STEM CELLX LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTOR: Dr E Kiss-Toth





SECRETARY: Dr E Kiss-Toth





REGISTERED OFFICE: 3 Greystones Rise
Sheffield
S11 7JP





REGISTERED NUMBER: 10466318 (England and Wales)





ACCOUNTANTS: Gibson Booth Limited
12 Victoria Road
Barnsley
South Yorkshire
S70 2BB

STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

BALANCE SHEET
31 DECEMBER 2024

31.12.24 31.12.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 149,431 201,397
Tangible assets 5 2,807 2,090
Investments 6 139,724 15,045
291,962 218,532

CURRENT ASSETS
Debtors 7 792,007 427,576
Cash at bank 274,599 16,801
1,066,606 444,377
CREDITORS
Amounts falling due within one year 8 1,352,933 513,502
NET CURRENT LIABILITIES (286,327 ) (69,125 )
TOTAL ASSETS LESS CURRENT LIABILITIES 5,635 149,407

CAPITAL AND RESERVES
Called up share capital 9 1,166 1,122
Share premium 719,346 551,650
Retained earnings (714,877 ) (403,365 )
SHAREHOLDERS' FUNDS 5,635 149,407

STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

BALANCE SHEET - continued
31 DECEMBER 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 31 March 2025 and were signed by:





Dr E Kiss-Toth - Director


STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

Stem CellX Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest pound.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about Stem CellX Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Significant judgements and estimates
No judgements have been made in the process of applying the below accounting policies that have had the most significant effect on amounts recognised in the financial statements.

There are no key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that have a significant risk of causing material adjustment to the carrying amounts of assets and liabilities within the next financial year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT.

Turnover from the sale of goods is recognised when significant risks and rewards of ownership of the goods have transferred to the buyer, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably. This is usually on icosahedron of the sale.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Intellectual property is being amortised evenly over its estimated useful life of five years.

STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Computer equipment33% straight line
Plant and Machinery25% reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Investments
Unlisted investments are initially recognised at cost. Provision is made for any permanent diminution in value of unlisted investments.

Grants
Revenue grants are accounted for when receivable and are credited to the profit and loss account in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2024
and 31 December 2024 259,828
AMORTISATION
At 1 January 2024 58,431
Charge for year 51,966
At 31 December 2024 110,397
NET BOOK VALUE
At 31 December 2024 149,431
At 31 December 2023 201,397

STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 January 2024 2,050 1,264 3,314
Additions - 1,331 1,331
Disposals - (666 ) (666 )
At 31 December 2024 2,050 1,929 3,979
DEPRECIATION
At 1 January 2024 - 1,224 1,224
Charge for year 513 101 614
Eliminated on disposal - (666 ) (666 )
At 31 December 2024 513 659 1,172
NET BOOK VALUE
At 31 December 2024 1,537 1,270 2,807
At 31 December 2023 2,050 40 2,090

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 January 2024 15,045
Additions 133,029
Disposals (8,350 )
At 31 December 2024 139,724
NET BOOK VALUE
At 31 December 2024 139,724
At 31 December 2023 15,045

STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors 748,218 408,189
Amounts owed by group undertakings 4,041 18,549
Other debtors 1,023 7
VAT 38,457 566
Prepayments and accrued income 268 265
792,007 427,576

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade creditors 1,349,195 503,399
Social security and other taxes - 598
Other creditors 1,905 8,171
Directors' current accounts 635 635
Accrued expenses 1,198 699
1,352,933 513,502

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
842 A Ordinary 1 886 842
280 B Ordinary 1 280 280
1,166 1,122

44 A Ordinary shares of 1 each were allotted and fully paid for cash at par during the year.

STEM CELLX LIMITED (REGISTERED NUMBER: 10466318)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

10. RELATED PARTY DISCLOSURES

Transactions with other group companies

31.12.24 31.12.23
£ £
Amounts repaid from related parties 14,508
Amounts paid to related parties - 18,549
Amounts due from related parties at the year end 4,041 18,549